文献速递免疫规划传染病防控与疫情报告

COVID-19疫苗——长期免疫衰退与突破性感染

COVID-19 vaccine - Long term immune decline and breakthrough infections.
PubMed 文献 · Vaccine · 2021-10-30

该前瞻性纵向研究纳入100名已接种疫苗的医护人员,每月检测抗体滴度、每两周及有临床指征时进行SARS-CoV-2 PCR检测,随访5个月。第二剂接种后1个月抗体滴度达峰,随后快速下降,接种后4个月平均抗体水平为峰值的6%。研究期间诊断4例突破性感染,均为无症状或轻症,感染后抗体滴度急剧升高。

要点

  • 第二剂疫苗接种后1个月抗体滴度达峰,之后快速下降,4个月时平均抗体水平为峰值的6%。
  • 研究期间诊断4例突破性感染,其中2例无症状、2例轻症。
  • 突破性感染后可见抗体滴度急剧升高。

核心结论

  • 第二剂疫苗接种后1个月抗体滴度快速下降。
  • 研究期间所有感染均为轻症或无症状,感染后可见滴度升高。

研究设计与样本

  • 5个月纵向前瞻性研究,纳入已接种疫苗的医护人员100名。
  • 每月检测抗体滴度,每两周及有临床指征时采样进行SARS-COV-2聚合酶链反应(PCR)检测,以确定抗体下降和突破性感染。

主要发现

  • 抗体滴度在第二剂疫苗接种后1个月达峰,此后快速下降:第二剂接种当日及此后每月中位抗体水平分别为895、22,266、9,682、2,554和1,401 AU/ml。
  • 接种后4个月,平均抗体水平为峰值水平的6%。
  • 研究期间诊断4例突破性感染,其中2例无症状,其余2例为轻症;感染后可见抗体滴度急剧升高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since the introduction of BNT162b2 mRNA COVID-19 vaccine by Pfizer in late 2020, efficacy and immunogenicity waning of COVID-19 vaccines was reported, and decision making regarding a booster remains a top priority worldwide, a decision that should be made based on breakthrough infection rate and antibody titer decline overtime. METHODS: We conducted a 5-month longitudinal prospective study involving vaccinated healthcare personnel, who were tested monthly for antibody titer, and sampled biweekly and on clinical indication for SARS-COV-2 polymerase chain reaction (PCR), to determine antibody decline and breakthrough infection. RESULTS: 100 participants were recruited to the study. Antibody titer reached the climate after one month of the second dose of the vaccine, and declined rapidly thereafter: the median antibody levels were 895; 22,266; 9,682; 2,554 and 1,401 AU/ml in the day of the second dose, and in one month interval thereafter, respectively. In other words, four months after vaccination, the mean antibody level was 6% of the peak levels. During the study period, 4 breakthrough infections were diagnosed, 2 of which were asymptomatic, and the remaining two were mild cases; sharp elevation of antibody titer was seen after infection. CONCLUSION: Antibody titer drops rapidly one month after the second dose of the vaccine. All infections within the study period were mild or asymptomatic, after which titer elevations were seen.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Khoury J, Najjar-Debbiny R, Hanna A, et al. COVID-19 vaccine - Long term immune decline and breakthrough infections. Vaccine. 2021. PMID: 34763949. doi:10.1016/j.vaccine.2021.10.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。